Clinical Trial Update: A Study to Evaluate the Effect of Losmapimod on Cardiac Conduction as Compared to Placebo and Moxifloxacin [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the effect of Losmapimod on cardiac conduction in acute coronary syndrome, comparing it with placebo and moxifloxacin; the trial has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• Losmapimod (losmapimod)
• Moxifloxacin (moxifloxacin)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Acute Coronary Syndrome | Phase 1 | Status: COMPLETED